Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool February 28, 2007 Brian Lawler	Bristol-Myers Stays Out of Trouble A federal monitor finds Bristol-Myers does not have to pay up over a questionable business deal.
The Motley Fool December 26, 2006 Brian Lawler	Bristol-Myers in the Giving Spirit The pharmaceutical finally settled with the U.S. DOJ and various state attorneys general over allegations that it was artificially inflating stated wholesale drug prices in order to gouge consumers and government health-care programs. What does it mean to investors?
The Motley Fool August 3, 2005 W.D. Crotty	Time Warner: Waning Vitality The long-suffering shareholders of media giant Time Warner are paying a hefty price -- $3 billion dollars in cold cash. That's the reserve set aside to settle lawsuits regarding the overstatement of revenue at AOL between 1999 and 2002.
The Motley Fool January 29, 2007 Brian Lawler	Bristol-Myers Blames the Generic Again The fourth quarter's financial results are dominated by generic competition.
The Motley Fool September 13, 2006 Brian Lawler	What to Make of Bristol-Myers Take a good look at the industry to try to sort out the meaning of all the news and the rumors. Investing in a company based on a possible buyout is never a good idea when the possibility is based solely on rumors and analyst speculation.
InternetNews December 15, 2004 Tim Gray	Time Warner Settles Fraud Case Time Warner said today that it has agreed to pay $210 million in criminal and civil fines to settle a federal fraud case stemming from allegedly shady advertising deals within its America Online division.
National Defense November 2011 Piazza & Ayers	Regulators Flex Foreign Corrupt Practices Act Enforcement Muscles Continuing a trend that started late in the last decade, the Securities and Exchange Commission this year continues to raise the bar on the enforcement of the Foreign Corrupt Practices Act of 1977.
The Motley Fool March 30, 2009 Brian Orelli	Here's Some Cash. Go Away. Bristol-Myers Squibb has to pay $2.1 million to settle a Federal Trade Commission investigation.
The Motley Fool August 10, 2006 Tim Beyers	TASER Tames Legal Tussles A shrewd settlement deal could prove to be very cheap. There's still good reason to remain skeptical of every news announcement that comes from TASER. Investors, take note.
The Motley Fool July 31, 2006 Stephen D. Simpson	More Plavix Headaches for Bristol-Myers Problems with a Plavix settlement put a large chunk of earnings at risk. Investors, take note.
Chemistry World October 7, 2015 Phillip Broadwith	Bristol-Myers-Squibb fined for alleged Chinese bribes The US Securities and Exchange Commission has fined New York based pharmaceutical company Bristol-Myers Squibb over $14 million over alleged bribes made to Chinese state owned hospitals.
The Motley Fool August 1, 2008 Brian Lawler	Is $60 a Share Enough for ImClone? Bristol-Myers Squibb announced a $60-per-share offer for ImClone Systems, but are shareholders going to go for the deal?
On Wall Street October 1, 2009 Thomas O. Gorman	SEC v. Bank of America: Where to Go From Here? The SEC thought it had completed an investigation, brought an enforcement action and then settled it.
The Motley Fool October 2, 2007 Billy Fisher	Closure for Bristol-Myers Bristol-Myers will pay $515 million to resolve cases from state and federal authorities alleging that the company promoted products for uses that hadn't been approved by the FDA.
PC World August 5, 2002 Joris Evers	Microsoft Set to Act on Antitrust Settlement Software giant will carry out part of the proposed deal with the DOJ, even though judge has yet to approve it.
InternetNews April 11, 2011	Google Deal for ITA Moving Forward The U.S. Department of Justice has opened the way for search giant Google to purchase the leading supplier of flight search technology.
Investment Advisor April 2009 James J. Green	B/D Briefing: Calm Before the Storm? A new report found that the average securities class action settlement was halved in 2008, but the authors of Securities Class Action Settlements: 2008 Review and Analysis, caution that the reported decrease doesn't constitute a trend.
Registered Rep. March 15, 2012 Kristen French	Due Diligence: Step Back Rakoff, SEC-Citigroup Settlement Could Stand Judge Jed Rakoff may have overstepped his authority, said a federal appeals court today. In a procedural decision, the court wrote that the Securities and Exchange Commission has a good chance of overturning Rakoff's rejection of a $285 million SEC settlement with Citigroup.
InternetNews January 6, 2004 Colin Haley	IBM Korea Scandal Prompts U.S. Inquiries The DOJ and SEC are reportedly looking into bribery and bid-rigging allegations against the IT giant's South Korean subsidiary.
The Motley Fool May 30, 2008 Brian Lawler	Bristol-Myers' Cheap Pipeline Bet Bristol-Myers announces that it is acquiring development-stage drugmaker Kosan Biosciences for a net price of $190 million in cash.
InternetNews September 25, 2009	Judge's Order Keeps Google Books in Limbo New York judge postpones fairness hearing for controversial settlement agreement in response to DoJ objections.
The Motley Fool February 21, 2007 Mary Dalrymple	Life Settlements Laid Out Understand this new marketplace before considering selling your life insurance.
Registered Rep. August 7, 2008 John Churchill	Citi Settles With SEC and Cuomo Over ARS Failure The firm has agreed to buy back auction rate securities sold to institutional and retail investors nationwide who've been stuck with the illiquid investment vehicles since February 12, 2008.
The Motley Fool February 25, 2011 Todd Wenning	Dividend Report Card: Bristol-Myers Squibb How does the pharma giant's dividend stack up?
The Motley Fool January 27, 2005 Stephen D. Simpson	Generics Bout Gets Bloody Bristol-Myers Squibb struggles to keep growing amid patent expirations.
The Motley Fool October 30, 2006 Brian Lawler	Sales Slow Down for Bristol-Myers Plavix isn't the only drug facing a challenging future. Losing patent protection and facing generic competition can be disastrous to sales and earnings if a pharmaceutical company doesn't have a way to drive revenue growth. Investors, take note.
InternetNews July 20, 2004 Roy Mark	Court Touts Microsoft's Settlement Compliance Status report of Microsoft's settlement with the Department of Justice checks up on its progress, including complaints about a licensing program.
The Motley Fool December 31, 2004 W.D. Crotty	HealthSouth's Payment Plan The health-care provider's stock is up on settlement news, but buyers should beware.
The Motley Fool June 17, 2005 Tom Taulli	Andersen, Part Deux? It looks as if Andersen isn't the only accounting firm with troubles. But should KPMG suffer the same fate?
The Motley Fool July 28, 2005 Stephen D. Simpson	Bristol-Myers' Road to Better Health Bristol-Myers looks toward 2007 and a resumption of real growth. For now, things could be a lot worse. At least investors can't say they're not getting paid to be patient.
InternetNews August 4, 2010	HP, DoJ Reach Deal to Settle Kickback Case Without admitting guilt, the computing giant has reached a settlement with authorities at the Department of Justice to resolve allegations that it provided kickbacks to win government contracts.
The Motley Fool April 27, 2006 Stephen D. Simpson	A Sluggish Bristol-Myers Squibb Generic erosion is going to chew away revenue and profits. Investors, at today's prices, there are just too many other better ideas to go after.
Registered Rep. December 11, 2008	SEC Finalizes $30 Billion ARS Settlement With Citi And UBS The $30 billion settlement is the largest in SEC history and restores liquidity to ARS investors at par value of their holdings.
The Motley Fool October 2, 2009 Robert Brokamp	Let's Fix the Rules of Enforcement Is the SEC up to the task?
InternetNews February 5, 2010	DoJ Still Wary About Google Book Settlement Federal attorneys say amended settlement still doesn't address fundamental antitrust and copyright concerns.
InternetNews September 11, 2007 Stuart J. Johnston	States Request Microsoft Oversight Extension At a hearing Tuesday regarding the pending expiration of much of Microsoft's antitrust settlement, a group of states requested continued oversight of the software giant.
The Motley Fool July 10, 2007 Brian Orelli	Sometimes, the Same Is Good Enough Bristol-Myers Squibb's new drug doesn't work better, but it's easier to take. Investors, take note.
The Motley Fool December 14, 2004 Brian Gorman	Bristol-Myers' Smart Moves Although problems still hang over the company, Bristol-Myers is paving the way for recovery. In the meantime investors will surely be jittery.
Information Today August 6, 2009	Library Groups Advise DOJ on Google Book Settlement The groups requested the Antitrust Division to advise the court presiding over the Google Book Settlement to supervise the implementation of the settlement closely, particularly the pricing of institutional subscriptions and the selection of the Book Rights Registry board members.
The Motley Fool September 25, 2007 Billy Fisher	Bristol-Myers Buys In to Biologics Looking to advance its biologics strategy, Bristol-Myers Squibb announces it will acquire Adnexus Therapeutics, a privately held developer of biologics.
The Motley Fool April 28, 2008 Brian Lawler	Bristol-Myers' Comeback Continues The pharmaceutical's first quarter brings more robust results.
The Motley Fool January 8, 2004 Rich Smith	Oops, I(BM) Did it Again Once again IBM finds itself embattled in bribing controversy abroad.
The Motley Fool November 17, 2009 Brian Orelli	Up 80%, It's Time to Sell Bristol-Myers to Mead Johnson: It's time to walk on your own. Investors will have an option of exchanging some or all of their Bristol-Myers shares for shares in Mead Johnson for a slight discount
Information Today September 24, 2009	Google Book Search Settlement Hearing to Be Postponed On Sept. 22, the parties involved in the Google Book Search settlement have asked the federal court to postpone the scheduled Oct. 7 hearing to give them time to work with the U.S. Department of Justice so that the parties can amend the Settlement Agreement.
InternetNews July 21, 2004 Roy Mark	DOJ Makes Compliance Visit to Microsoft Investigators make scheduled check-up trek to Redmond to make sure the company is complying.
The Motley Fool July 29, 2011 Brian Orelli	Bristol-Myers Grows in the Wrong Places Bristol-Myers has a solid quarter, but Plavix and currency movements aren't important.
The Motley Fool June 30, 2010 Brian Orelli	Is Bristol-Myers Squibb a Buy? Bristol-Myers is a better buy than Eli Lilly for one major reason: its resources.
BusinessWeek May 20, 2010 Jesse Westbrook & David Scheer	How Big a Hit Will Goldman Take? Congress and the public expect the SEC to extract a big fine
The Motley Fool August 15, 2006 Stephen D. Simpson	Twirling the Barr Look closely and you'll see that Barr posted a solid quarter. Investors, if you haven't checked this one out yet, now may be the time for a little due diligence.
InternetNews August 31, 2006 Roy Mark	DoJ, Microsoft Sign Up For Two More Years The Department of Justice and Microsoft put the final legal touches Wednesday on their May agreement to extend by two years the communications protocol licensing program portion of Microsoft's antitrust agreement with the government.